BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7021676)

  • 1. How complement kills E. coli. II. The apparent two-hit nature of the lethal event.
    Wright SD; Levine RP
    J Immunol; 1981 Sep; 127(3):1152-6. PubMed ID: 7021676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How complement kills E. coli. I. Location of the lethal lesion.
    Wright SD; Levine RP
    J Immunol; 1981 Sep; 127(3):1146-51. PubMed ID: 6267132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-mediated inhibition of function in complement-resistant Escherichia coli.
    Dankert JR
    J Immunol; 1989 Mar; 142(5):1591-5. PubMed ID: 2645364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deposition of C5b-9 complexes and its precursors on E. coli J5 during complement activation enhances uptake and toxicities of gentamicin.
    Bloch EF; Morrison K; McDonald-Pinkett S; Baskin S; Campbell S; Peters S; Dillahunt S; Evans D; Lucas S; Macatangay A; Kanaan Y
    Immunol Invest; 2008; 37(3):245-61. PubMed ID: 18389443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The attack phase of human complement: differentiation between membrane binding and complex formation by the detection of neoantigen expression in situ. A morphometric immunoferritin study.
    Balkarowa-Ständer J; Rother U; Rauterberg EW
    J Immunol; 1981 Sep; 127(3):1089-93. PubMed ID: 7264298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moculating effect of the late-acting components of the complement system on the bactericidal activity of human polymorphonuclear leukocytes on E. coli 0111:B4.
    Tedesco F; Rottini G; Patriarca P
    J Immunol; 1981 Nov; 127(5):1910-5. PubMed ID: 7028865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of various compounds on lysis of antibody-coated sheep erythrocytes by hypotonic shock or complement.
    Müller-Peddinghaus R; Erdtmann K
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):287-92. PubMed ID: 6748820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of sheep red cells in neat autologous serum as a source of antibody and complement.
    Borsos T; Circolo A
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():5-9. PubMed ID: 6587743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
    Deng J; Gold D; LoVerde PT; Fishelson Z
    Int J Parasitol; 2007 Jan; 37(1):67-75. PubMed ID: 17123534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-hit mechanism of tumour cell killing by radiation.
    Chapman JD
    Int J Radiat Biol; 2003 Feb; 79(2):71-81. PubMed ID: 12569011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanism of acquired resistance to complement-mediated lysis by Entamoeba histolytica.
    Gutiérrez-Kobeh L; Cabrera N; Pérez-Montfort R
    J Parasitol; 1997 Apr; 83(2):234-41. PubMed ID: 9105303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
    Brannen CL; Sodetz JM
    Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human serum complement requirements for bacterial killing and protoplast lysis of Escherichia coli ML308 225.
    Allen RJ; Scott GK
    J Gen Microbiol; 1981 Mar; 123(1):179-81. PubMed ID: 7033454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-capsular antibodies activate killing of Escherichia coli O8:K87 by the alternate complement pathway in porcine serum.
    Clark NM; Berberov EM; Wang M; Moxley RA
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):185-91. PubMed ID: 16919781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics.
    Koski CL; Ramm LE; Hammer CH; Mayer MM; Shin ML
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3816-20. PubMed ID: 6602341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane.
    Hu VW; Esser AF; Podack ER; Wisnieski BJ
    J Immunol; 1981 Jul; 127(1):380-6. PubMed ID: 7240749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with Treponema pallidum outer membrane vesicles induces high-titer complement-dependent treponemicidal activity and aggregation of T. pallidum rare outer membrane proteins (TROMPs).
    Blanco DR; Champion CI; Lewinski MA; Shang ES; Simkins SG; Miller JN; Lovett MA
    J Immunol; 1999 Sep; 163(5):2741-6. PubMed ID: 10453016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragmented tissue factor pathway inhibitor (TFPI) and TFPI C-terminal peptides eliminate serum-resistant Escherichia coli from blood cultures.
    Schirm S; Liu X; Jennings LL; Jedrzejewski P; Dai Y; Hardy S
    J Infect Dis; 2009 Jun; 199(12):1807-15. PubMed ID: 19456231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.